"Stopping the itch": mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia
Authors
Enbiale, WBaynie, TB
Ayalew, A
Gebrehiwot, T
Getanew, T
Ayal, A
Ayalew, M
De Vries, HJ
Takarinda, K
Manzi, M
Zachriah, R
Issue Date
2020-06-30Submitted date
2020-07-25
Metadata
Show full item recordAbstract
Introduction: In 2018, the Ethiopian Ministry of Health embarked on a Mass Drug Administration (MDA) campaign that involved over 9 million people in Ethiopia - the largest scabies MDA campaign ever conducted on a global level. We describe its implementation and report on a) numbers screened and identified with scabies, b) treatment category and drug type and c) human resources used, duration, and cost of the campaign. Methodology: The MDA campaign was conducted according to national guidelines and activities including: planning and organization, engagement of local leaders, community mobilisation and advocacy, awareness-raising among health workers, field implementation, and monitoring and evaluation. The campaign was conducted between July and August 2018. Results: The MDA campaign was implemented by about 15,000 people, mostly from the community, over an average of 6 days and reached 9, 057, 427 people. A total of 875,890 (9.7%) scabies cases were detected and 995,471 (11.0%) contacts received treatment. (Contact-to-case ratio = 1.3). Scabies prevalence varied, the highest prevalence was seen in Central Gondar (39.2%), South Gondar (16.7%) and North Gondar (15.0%), these neighbouring zones contributing more than two third of all scabies cases in the region. Of 1,738,304 (93%) who received treatment, 94% received ivermectin, the rest topical permethrin and sulfur. The average coverage capacity of an MDA campaign staff member was 84 people per day. The total cost was 11,696,333 United States Dollars (USD). Cost per 100,000 population = 129,135 USD. Conclusions: This experience of rapid-large scale implementation would be useful to scale up similar interventions and "stop the itch" in other regions of Ethiopia.PubMed ID
32614793Type
ArticleLanguage
enEISSN
1972-2680ae974a485f413a2113503eed53cd6c53
10.3855/jidc.11701
Scopus Count
Collections
Related articles
- Does mass drug administration for community-based scabies control works? The experience in Ethiopia.
- Authors: Enbiale W, Ayalew A, Gebrehiwot T, Mulu Y, Azage M, Zachariah R, Romani L, Verdonck K, Van Griensven J, De Vries HJ
- Issue date: 2020 Jun 29
- Suicidal Ideation
- Authors: Harmer B, Lee S, Duong TvH, Saadabadi A
- Issue date: 2020 Jan
- Coverage, social mobilization and challenges of mass Zithromax administration campaign in South and South East zones of Tigray, Northern Ethiopia: A cross sectional study.
- Authors: Mulugeta A, Gebregergs GB, Asfaw S, Yemane D, Mitiku M, Meresa B, Gigar G, Kidane A
- Issue date: 2018 Feb
- Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.
- Authors: Romani L, Marks M, Sokana O, Nasi T, Kamoriki B, Cordell B, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Kaldor JM, Steer AC
- Issue date: 2019 May
- Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study).
- Authors: Lake SJ, Phelan SL, Engelman D, Sokana O, Nasi T, Boara D, Gorae C, Schuster T, Grobler AC, Osti MH, Andrews R, Marks M, Whitfeld MJ, Romani L, Kaldor J, Steer A
- Issue date: 2020 Aug 30